- NEWS
- Correction 08 October 2021
Scientists hail historic malaria vaccine approval — but point to challenges ahead
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-021-02755-5
Updates & Corrections
-
Correction 08 October 2021: An earlier version of this story incorrectly attributed the finding that the RTS,S vaccine could prevent the deaths of 23,000 children a year if a full series of doses were distributed to kids in countries with a high incidence of malaria. The correct attribution is a 2020 PLoS Medicine article.
References
RTS,S Clinical Trials Partnership Lancet 386, 31–45 (2015).
Hogan, A. B., Winskill, P. & Ghani, A. C. PLoS Med. 17, e1003377 (2020)
Chandramohan, D. et al. N. Engl. J. Med. 385, 1005–1017 (2021).